Ann: Becoming a substantial holder, page-15

Maybe not Pseudo science but certainly not cutting edge AAA quality when dealing with peoples responses to pain.
"Does it still hurt?"
"Dunno too wasted"
"Well at least you haven't died".
It was very safe (the drug) and the research certainly adds to the body of scientific knowledge which is actually how science is supposed to operate. I agree with others that its a bit of a stitch up but that's business and it doesn't mean its all bad at all. Money makes money and the next two years could be the holy grail for ZLD. We just need some sort of incident (or incidence) from the product of rival cannabis stock companies so that the IP around things such as safety, tolerance and dosages becomes very meaningful. Then its Zelda to the moon.